Reducing cardiovascular risk in the patient with elevated triglycerides

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.


Speaker Name/Credentials

Alan S. Brown, M.D.

Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital Clinical Associate Professor, Loyola University Medical Center

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.0 credits


This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia.

This presentation was created and presented before the results of the REDUCE-IT trial were released.

Learning Objectives

1. Understand the effect of hypertriglyceridemia on CHD risk.

2. Review treatment strategies to reduce risk of pancreatitis and CHD events.

3. Review appropriate therapies for patients with elevated triglycerides.


Speaker  – Amgen, Regeneron, Sanofi, Advisory Board- Amarin, Kastle, Kowa, Pfizer, Sanofi

This enduring material activity, Reducing cardiovascular risk in the patient with elevated tryglycerides, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins March 29, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Share this: